Specialty Pharmacy

Research may lead to the development of new types of binding proteins for biological sugar structures, which play a significant role in cancer and infectious diseases.

Patients with a history of cancer have a greater likelihood of developing atrial fibrillation, the most common heart rhythm disorder, compared with the general population.

The new study has found that the lymphedema monitoring technology, marketed by LymphaTech, can effectively detect early arm swelling associated with lymphedema in breast cancer patients.

Trastuzumab-dttb was first approved in January 2019 across all eligible indications, mainly adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer.

The FDA has issued a new guidance to sponsors and health care providers regarding certain Risk Evaluation and Mitigation Strategy-required testing during the coronavirus disease 2019 pandemic.

The phase 3 trial showed a statistically significant improvement in overall survival (OS) and composite complete remission rate.

The growth of the pipeline has led to increases in insurance carriers’ specialty plan spend.

Pharmacy Moms Group special task force develops guidelines as precautions are implemented amid the COVID-19 pandemic.

Only 15% of those at risk are currently using PrEP.

Statins, widely used to lower cholesterol and prevent heart disease, may guard against heart damage caused by certain breast cancer therapies.

The 12 groups represent practice settings of nearly all pharmacists in the United States.

“We’re pretty devastated,” said Jessica Harris, a friend of Rutter, in an interview with WFSB. “She beat cancer and lost the battle to coronavirus—it’s just crazy.”

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

The drug was previously approved to treat HCV in adults

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

Now is the time for pharmacists to stand even taller and provide more help to their communities.

A new study shows that the advantages of digital breast tomosynthesis are maintained over multiple years and rounds of screening compared with digital mammography.

A clinical program evaluating sarilumab (Kevzara, Sanofi and Regeneron) has started in patients hospitalized with a severe form of the novel coronavirus (COVID-19), according to the company.

A growth hormone known as insulin-like growth factor-1 has been found to play a role in the development of breast cancer.

Top news from across the health care landscape.

Top news from across the health care landscape.

Top news of the week from Directions in Specialty PharmacyTM.

New research shows targeting stromal cells may be an effective way of overcoming resistance to chemotherapy and radiation in patients with glioblastoma, a deadly brain cancer.

A bipartisan coalition in Congress has introduced new legislation designed to ensure Medicare patients have access to Part B home infusion medications.

The FDA has approved nivolumab plus ipilimumab injections for intravenous use to treat hepatocellular carcinoma in patients who have been previously treated with sorafenib.

Top news from across the health care landscape.

Novel approaches such as telemedicine may be a way to reach rural patients with cancer, according to a panel discussion at the Hematology/Oncology Pharmacists Association 2020 Meeting

Lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients with cancer face specific barriers when seeking medical care, but pharmacists and other medical professionals can take specific steps to reduce the gaps in care.

Top news of the week across the healthcare landscape.

Due to the uniqueness of each disease state and motivations of each player in the market to capture revenue from the growing industry, there is an abundance of specialty pharmacy solutions available in the market.